Suppressive effects of indomethacin on crystal-induced inflammation in canine joints and on neutrophilic motility in vitro.
D000208:Acute Disease; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001168:Arthritis; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004487:Edema / Q000139:chemically induced; D005122:Exudates and Transudates / Q000187:drug effects; D006073:Gout; D006614:Hindlimb; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007213:Indomethacin / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D007249:Inflammation / Q000139:chemically induced*; D007592:Joint Diseases / Q000139:chemically induced*; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects*; D011868:Radioisotopes; D013582:Synovial Fluid; D014527:Uric Acid; D014978:Xenon
D000893:Anti-Inflammatory Agents; D011868:Radioisotopes; D014527:Uric Acid; D014978:Xenon; D007213:Indomethacin